98326981 - STIPLEX

Information

• Trademark
• 98326981

• Source

• Serial Number

  98326981

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  December 21, 2023
  12 months ago

• Transaction Date

  October 31, 2024
  a month ago

• Status Date

  October 31, 2024
  a month ago

• Location Date

  October 31, 2024
  a month ago

• Status Code

  661

• Current Location

  TMO LAW OFFICE 120

  Employee Name

  DUFFIN, GRACE

• Attorney Docket Number

  T-5040 US

  Attorney Name

  Sydney R. Jensen

  Law Office Assigned Location Code

  N20

• Owners

  • SpeeDx Pty Ltd

Case File Statements

• DM0000: The mark consists of the stylized word STIPlex.
• GS0051: Pharmaceutical and veterinary preparations and substances consisting of catalytic DNA molecules being diagnostic reagents and preparations, except for medical or veterinary use for the purpose of detection and identification of pathogens, for the detection of antibiotic resistance, and medical diagnostic reagents for the analysis of body fluids specifically for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, and for analysis of response to therapy and preparations for detecting and preparations for analysis of gene expression specifically for medical or medical research purposes; reagents for medical and veterinary use; nucleic acid amplification reagents for medical use; nucleic acid sequencing preparations being nucleic acid sequences for medical use; chemical preparations containing enzymes for medical purposes specifically for the diagnosis of diseases or detection or identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy; chemical preparations containing enzymes for pharmaceutical, veterinary and medical purposes specifically for the diagnosis of diseases or detection or identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy; enzymes for pharmaceutical, veterinary and medical purposes specifically for the diagnosis of diseases or detection or identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy; medical kits containing medical diagnostic reagents for testing and analysis of bodily fluids for use in disease detection and/or analysis of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, and immune-suppression and immune disorders, for genotyping; diagnostic preparations for medical or veterinary use; biological chemical diagnostic test kits in the nature of medical diagnostic reagents and assays for testing body fluids for the presence of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders;
• CC0000: Color is not claimed as a feature of the mark.
• GS0011: Reagents for scientific or medical research use; enzymes for industrial or scientific purposes; nucleic acid for other than medical and veterinary purposes; nucleic recombinant acid for other than medical and veterinary purposes; acids namely inorganic acids for industrial purposes; DNA polymerase for scientific purposes; chemicals used in environmental monitoring in the nature of chemical preparations for scientific purposes, other than for medical or veterinary use;
• GS0441: Medical services; human healthcare services; medical testing services relating to the diagnosis and treatment of disease; genetic testing for medical purposes; medical and health care services specifically dna, genetics and genetic testing for medical purposes; medical diagnostic services in the nature of medical testing and medical analysis services for diagnostic purposes provided by medical laboratories; medical diagnostic imaging and molecular medicine being medical services; molecular medical diagnostics testing;
• GS0101: Surgical apparatus and instruments; medical instrument for diagnostic use, namely, apparatus for medical diagnostic testing to diagnose and identify pathogens, infections, and infectious diseases, or other tissue-based diagnostic testing, cytology and cell-based testing specifically for the purposes of analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy; medical diagnostic apparatus for diagnosis and identification of, infections, and infectious diseases; diagnostic testing kits consisting primarily of medical apparatus and instruments for testing of bodily fluids for use in disease detection, namely, to diagnose and identify pathogens, infections, and infectious diseases; point of care medical devices, namely, a device for testing for diagnosis of disease, detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy for treatment of infectious diseases, immunological diseases and autoimmune diseases; medical screening kits comprised of medical screening and testing apparatus for the diagnosis of disease, detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired and inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy; biological chemical test kits containing diagnostic preparations for medical purposes used in medical laboratories in the nature of nucleic acid substrates used for analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders;
• GS0421: Scientific and technological services and research and design relating thereto, namely, DNA analysis services for scientific research purposes, scientific research consulting in the field of genetics; scientific research in the field of genetics; genetic engineering services for scientific purposes; scientific research in the field of genetics and genetic engineering; scientific research relating to genetics; research relating to chemistry; scientific research relating to chemistry; research in the field of chemistry; product development of medical diagnostic apparatus; design of medical diagnostic apparatus; research relating to molecular sciences; biological, bacteriological, chemical, biochemical, dna, rna, protein, polynucleic acid and molecular analysis and evaluation services to diagnose and identify pathogens, infections, and infectious diseases for medical or scientific research purposes; dna and rna and polynucleic acid and protein sequencing, analysis and evaluation services for scientific purposes; genome sequencing services and the analysis and evaluation of data resulting therefrom in the nature of genetic testing for scientific research purposes; scientific research namely provision of reports relating to scientific and medical experiments, the results of scientific and medical experiments and tests, the analysis and evaluation of scientific and medical data, and data generated by scientific and medical experiments and tests; scientific and medical research and development services in the field of the diagnosis of disease, detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy; custom design and development of biochemical assays;

Case File Event Statements

• 12/21/2023 - 12 months ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 4/8/2024 - 8 months ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 7/22/2024 - 4 months ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 10/30/2024 - a month ago

  8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 10/30/2024 - a month ago

  7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 10/31/2024 - a month ago

  9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 7/30/2024 - 4 months ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 7/30/2024 - 4 months ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 7/30/2024 - 4 months ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN